We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00230906
First Posted: October 3, 2005
Last Update Posted: December 28, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Nissho Nipro Europe
Information provided by:
University Hospital, Ghent
September 29, 2005
October 3, 2005
December 28, 2007
January 2001
Not Provided
Concentration of uremic components after 3 weeks of haemodialysis
Same as current
Complete list of historical versions of study NCT00230906 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane
Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane
Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane
Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Haemodialysis
Procedure: Haemodialysis with either low or high flux membranes
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
12
April 2002
Not Provided

Inclusion Criteria:

  • Chronic haemodialysis patient
  • Serum albumin > 3.6 g/dl

Exclusion Criteria:

  • < 18 years
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Belgium
 
 
NCT00230906
2001/182
No
Not Provided
Not Provided
Not Provided
University Hospital, Ghent
Nissho Nipro Europe
Principal Investigator: Raymond Van Holder, MD, PhD University Hospital, Ghent
University Hospital, Ghent
December 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP